As per available reports about 1525 journals, 70 Conferences, 16 workshops are presently dedicated exclusively to Drug Development and about 439204 articles are being published on the current trends in Drug Development.In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Drug Development are being carried out. It was found that approximately only 1.9% of the journals had a 2017 impact factor of 10 or higher. 1. As a result of a revolution, and to improve the journal quality, the publisher decided to revise the aims and scope of Biomedical Research and Therapy. 2019 - Volume 80. The 2019-2020 Journal Impact IF of Drug Design, Development and Therapy is 3.216, which is just updated in 2020. The highest Journal Impact IF of Drug Design, Development and Therapy is 3.486. The lowest Journal Impact IF of Drug Design, Development and Therapy is 2.822. The total growth rate of Drug Design, Development and Therapy IF is 11.8%. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy. AJPCR provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Sciences. Explores the effect in different disease conditions of rationally developed, effective delivery systems. development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect "The Rules of 3" Aims & Scope Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. Poth, Aaron G., Chiu, Francis C.K. APPROVAL. 2016 - Volume 77. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Stanković, Tijana, Ranđelović, Teodora and 6 more Open Access March 31, 2021 Drug Design, Development and Therapy. ... Drug Design, Development and Therapy (Deadline: 30 November 2021) ... 15 December 2021) Therapy-Promoted Cancer Repopulation and Acquired Cell-Resistance: Beyond Gene Mutation (Deadline: 15 December 2021) Here you can find useful information. An international, peer-reviewed, Open Access journal that spans the spectrum of drug design and development through to clinical applications. The aim of this Special Issue is to illustrate the interdisciplinary research of […] P h a s e 3. PubMed A survey of 75 pharmaceutical, life sciences and medtech businesses indicates R&D spending is being maintained and is set to rise in 2021, despite Brexit and the impact of Covid-19. MedCrave Group LLC is a participating organization of the ORC i D proposal and authors are necessary to present their ORC i D figures at submission whenever available.. ORC i D?. 2021 - Volume 82. 2.010 Q1. . ORC i D is the source of a determined digital identifier that is unique to you. 2018 - Volume 79. Many of the drugs in current use were discovered by experiments conducted in animals and humans. Drug Design, Development and Therapy - Dove Press An international, peer-reviewed, Open Access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Impact factor measures the quality of the Journal. Novel Approaches in Drug Designing & Development is an interdisciplinary, peer reviewed open access journal that brings out most current research in fields related of Drug Design, Research focusing upon drug designing methodologies, new drugs developments in chemical and biological research. Applications of artificial intelligence in drug development using real-world data. A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. Impact Factor: *1.738 *2020 Journal Citation Reports (Clarivate, 2021) CiteScore™: 2.1 Delivering the latest industry insight into innovative early-stage research, techniques, and tools for optimizing new pharmaceutical development. Metabolism and transporter based drug–drug interaction of tacrolimus with nine co-medicated injections Technological and translational challenges for extracellular vesicle in therapy and diagnosis 261. Charles Oo, Barbara Ameer. More News Biomarker company raises £2.625 million for neuroscience drugs Published Date: 8 July 2021 Drug Design, Development and Therapy *§. The top 5% of journals had impact factors approximately equal to or greater than 6. Drug Design and Development. Nanomaterials for Drug Delivery and Therapy presents recent advances in the field of nanobiomaterials and their important applications in drug delivery, therapy and engineering. 6.84. Drug Design, Development and Therapy Journal Impact IF. Journal Impact Factor: 4.162 (5 year impact 4.278) What is the advantage to you of publishing in Drug Design, Development and Therapy? Publish. 2021 Oncotarget (Impact Factor 5.126, indexed PubMed) submitted for publication Date 28 May 2021, accepted for publication June 12, 2021 after extensive peer review. The Journal publishes current and comprehensive reviews, original research articles, short communications/letters, drug clinical trial studies and short reports. 2020 - Volume 81. 66.98. Lian LJ, Lin B, Cui X, He J, Wang Z, Lin XD, Ye WJ, Chen RJ, Sun W. Drug Design, Development and Therapy 2020, 14:4835-4843. The Journal of Medicinal Chemistry and Drug Design (JMCDD) (ISSN 2578-9589) presents up-to-date coverage of advanced drug systems and their applications in medicine. Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. Analgesic drug development: proof-of-mechanism and proof-of-concept in early phase clinical studies. The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. Current Pharmaceutical Design publishes timely in-depth/mini reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. The book offers pharmaceutical perspectives, exploring the development of … Development and Validation of UHPLC-MS/MS Assay for Therapeutic Drug Monitoring of High-dose Methotrexate in Children with Acute Lymphoblastic Leukemia. The Drug Design, Development and Therapy Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Drug Design, Development and Therapy during the two preceding years (2018-2019). The journal of Diabetes research and therapy is a high quality open access journal & discuss the diagnosis, treatment or control of diabetes, which is a disease caused by a problem in insulin production in the human body, that leads to a number of issues with the functioning of the body. Menu. Editor-in-Chief: Prof. Dr. Frank Boeckler. An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. PHASE. Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles. Drug Design, Development and Therapy - Journal Impact IF. However, much of the discipline’s application in the pharmaceutical industry remains enigmatic. Department of Immunology, Changzhi Medical College, Changzhi, Shanxi, 046000 China. Development of purified cashew gum mucoadhesive buccal tablets containing nystatin for treatment of oral candidiasis. In this special issue of Targeted Cancer Therapy, contributions are encouraged to discuss novel mechanisms or drug targets in cancer and new advancement in anti-cancer drug discovery and development. CLINICAL. Biology Special Issue “Boron Neutron Capture Therapy: From Nuclear Physics to Biomedicine” ISSN 2079-7737, Impact Factor 3.796. and 15 more Open Access June 30, 2021. However, many drugs are now being designed with the specific disorder in view. Drug design types depend on screening of a large number of molecules to distinguish and can select the most effective drug with high pharmaceutical effect. International Journal of Medical, Pharmacy and Drug Research is to publish papers in the field of Medical Science, Pharmacy Journal and Drug Research with impact factor and DOI. Zeeshan Ahmad, Ali Nokhodchi January 12, 2021. Navjot Kaur, Vanktesh Kumar, Surendra Kumar Nayak, Pankaj Wadhwa, Paranjit Kaur, Sanjeev Kumar Sahu, Chemical Biology & Drug Design. Partnership Opportunities in Drug Delivery (PODD) October 28-29, 2021 Boston, MA (Virtual & Live) Pharmapack Drug Delivery & Packaging October 13-14, 2021 Paris, France. The Journal of Pharmaceutical Sciences & Emerging Drugs (JPSED) promotes latest research that makes a significant contribution in advancing knowledge of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Journal Impact Report 2020-21 !! Initial IND (first in human) NDA/BLA Asian Journal of Phytomedicine and Clinical Research (AJPCR) This is an online Journal and international peer review Quarterly, scientific and professional journal emphasizing quality pharmaceutical discoveries and innovations. P h a s e 1. Drug design is an inventive effort of designing a suitable lead molecule to make it more active and safer with less toxicity than the original lead molecule that may properly bind with its specific receptor sites to produce a certain pharmacological effect. Department of Reproductive Medicine, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, 046000 China. Hepatology 55:742–748. Journal of Drug Research and Development (JDRD) presents up-to-date coverage of advanced drug systems and their innovative service to human health. *2020 Journal Impact Factor was established by dividing the number of articles published in 2018 and 2019 with the number of times they are cited in 2020 based on Google Scholar Citation Index database. The aim of Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. 2010 - 2019. Emerging Pharmaceutical Technologies For Novel Dosage Development. Original research articles, short communications, and critical review articles are welcome. Reviews and drug case histories on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Journal of Medicinal Chemistry. Articles & Issues. IMPACT FACTOR 5.923. Targeting protein self-association in drug design. It offers accelerated publication. 2110. Drug Design, Development and Therapy. RESEARCH. Dendrimers in Nanomedicine: Concept, Theory and Regulatory Perspectives provides the comprehensive overview of the latest research efforts in designing, optimising, development and scale-up of dendrimer-mediated delivery systems. IJMS. Jiang, Ting, Chen, Xisha and 3 more May 31, 2021. PRE. Submit Journal for Impact Factor 2020-21 Evaluation. Compared with historical Impact Factor data, the Impact Factor 2018 of Drug Design, Development and Therapy grew by 9.30% . The Impact Factor Quartile of Drug Design, Development and Therapy is Q1 . About. Each selected article will be freely available to read for a period of 1 month post publication. 14452. Download PDF. Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and … 2015 - Volume 76. Therapeutic strategies to overcome taxane resistance in cancer. P h a s e 2. Journals. It was found that approximately only 1.9% of the journals had a 2017 impact factor of 10 or higher. Previous Next. For example, Inrebiq, an antineoplastic used to treat certain types of myelofibrosis, received priority review and orphan drug and protected status in 2019, although it had similar efficacy to the myelofibrosis drug Jakafi, while also presenting a potentially higher toxicity profile and higher costs. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies. DISCOVERY. 2. Drugs play predominant role in human daily life and have a greater impact as well. 7.321 Impact Factor. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. 3. Machine learning directed drug formulation development. Current Drug Therapy publishes full-length/mini reviews of high quality on all the latest advances in drug therapy and drug clinical trial studies and guest edited thematic issues covering: new and existing drugs, therapies and medical devices.. Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences. Focuses on high-quality research on the development of novel drug delivery systems. CPT: Pharmacometrics & Systems Pharmacology (CPT:PSP) is a sibling journal to the well-established high impact journal, Clinical Pharmacology & Therapeutics (2013 Impact Factor, 7.39, Journal Citation Reports, Thomson Reuters, 2014). Journal Impact Factor: 1.5* Cellular & Molecular Medicine: Open access is a peer reviewed, open access journal that encompasses all fundamental and molecular aspects of Medicine. Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global genetic toxicology testing market is estimated to value at USD 1.90 billion in 2021 and is expected to grow at a CAGR of 10.0%. The top 5% of journals had impact factors approximately equal to or greater than 6. The journal provides a unique international forum for scientists in the pharmacometrics and systems pharmacology space. Additionally, each drug profile features information on the type of drug, current status of development, route of administration, target indications, and a … ISSN: 1177-8881 Está en índices de citas (Science Citation Index Expanded, Scopus) = … Find out more. Novel Approaches in Drug Designing & Development . Drug designing journals have been showing tremendous citations and articles focusing the most advanced research trends in the field of drug discovery, medicinal chemistry, Drug Design tools, protein engineering, bioinformatics. Pages: 825-837. in 2014 and 2015. Area of expertise - Medical oncology, clinical pharmacology, drug development, translational research Arya Amini, Duarte, California, United States of America Radiation Oncology Paul Baas, Amsterdam, Netherlands Development of new therapies and the treatment of lung cancer and malignant mesothelioma Paolo Bironzo, Torino, Italy Pages: 229-239. Del Piccolo, Nuala, Shirure, Venktesh S. and 6 more Open Access August 31, 2021. Gregor Fuhrmann, Claus-Michael Lehr, Raymond Schiffelers January 12, 2021. Articles & Issues. Find the Editor's Choice Articles here. The 2019-2020 Journal Impact IF of Drug Design, Development and Therapy is 3.216, which is just updated in 2020. The journal was established in 2007 and is published by Dove Medical Press . July 12-13, 2021 7th Global Public Health, Occupational Safety and Health Policy, Webinar, Webinar: July 13-14, 2021 4th International Conference & Expo on Aesthetic Medicine and Dermatology, Shanghai, China: July 13-14, 2021 11th International Conference on Herbal therapy and Acupuncture, Sydney, Australia: July 14-15, 2021 Das, Tuyelee, Anand, Uttpal and 5 more March 31, 2021. Abstract. Journal of Pharmaceutical Sciences and Drug Development with the Supreme system that provided by the IOMC Academy, promised to the academic world, do efforts to having a qualify journal. Sections. Drug Development Research will feature Editor's Choice Articles. Drug design is a long and costly process taking many stages; start with target identification passing through target validation, lead identification, and candidate optimization of pre-clinical and clinical trials. The news suggests that the Journal Citation Reports (JCR) database tracked all impact factors for more than 12000 journals. Expert Opinion on Drug Discovery. Ana Paula de Sá Pinto Abrahão Magalhães, Helena Keiko Toma, Flávia Almada do Carmo & Claudia Regina Elias Mansur. In other words, Drug design is an inventive effort of designin… Now Available. If 'X' is the total number of articles published in 2018 and 2019, and 'Y' is the number of times these articles were cited in indexed journals during 2020 then, journal impact factor = Y/X